313 related articles for article (PubMed ID: 21160022)
1. Canine subcutaneous mast cell tumors: cellular proliferation and KIT expression as prognostic indices.
Thompson JJ; Yager JA; Best SJ; Pearl DL; Coomber BL; Torres RN; Kiupel M; Foster RA
Vet Pathol; 2011 Jan; 48(1):169-81. PubMed ID: 21160022
[TBL] [Abstract][Full Text] [Related]
2. Cellular proliferation in canine cutaneous mast cell tumors: associations with c-KIT and its role in prognostication.
Webster JD; Yuzbasiyan-Gurkan V; Miller RA; Kaneene JB; Kiupel M
Vet Pathol; 2007 May; 44(3):298-308. PubMed ID: 17491070
[TBL] [Abstract][Full Text] [Related]
3. Identification of c-kit mutations-independent neoplastic cell proliferation of canine mast cells.
Ohmori K; Kawarai S; Yasuda N; Tanaka A; Matsuda H; Nishimura R; Sasaki N; Tsujimoto H; Masuda K
Vet Immunol Immunopathol; 2008 Nov; 126(1-2):43-53. PubMed ID: 18687474
[TBL] [Abstract][Full Text] [Related]
4. Ki67/KIT double immunohistochemical staining in cutaneous mast cell tumors from Boxer dogs.
Fonseca-Alves CE; Bento DD; Torres-Neto R; Werner J; Kitchell B; Laufer-Amorim R
Res Vet Sci; 2015 Oct; 102():122-6. PubMed ID: 26412531
[TBL] [Abstract][Full Text] [Related]
5. Aberrant autophosphorylation of c-Kit receptor in canine mast cell tumor cell lines.
Takeuchi Y; Fujino Y; Watanabe M; Nakagawa T; Ohno K; Sasaki N; Sugano S; Tsujimoto H
Vet Immunol Immunopathol; 2010 Oct; 137(3-4):208-16. PubMed ID: 20591500
[TBL] [Abstract][Full Text] [Related]
6. Expression of proto-oncogene C-kit and correlation with morphological evaluations in canine cutaneous mast cell tumors.
Passantino L; Passantino G; Cianciotta A; Ribaud MR; Lo Presti G; Ranieri G; Perillo A
Immunopharmacol Immunotoxicol; 2008; 30(3):609-21. PubMed ID: 18608529
[TBL] [Abstract][Full Text] [Related]
7. Canine subcutaneous mast cell tumor: characterization and prognostic indices.
Thompson JJ; Pearl DL; Yager JA; Best SJ; Coomber BL; Foster RA
Vet Pathol; 2011 Jan; 48(1):156-68. PubMed ID: 21078881
[TBL] [Abstract][Full Text] [Related]
8. Canine gastrointestinal stromal tumors: immunohistochemical expression of CD34 and examination of prognostic indicators including proliferation markers Ki67 and AgNOR.
Gillespie V; Baer K; Farrelly J; Craft D; Luong R
Vet Pathol; 2011 Jan; 48(1):283-91. PubMed ID: 20826846
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of internal tandem duplications in the c-kit of dogs with multiple mast cell tumours.
Amagai Y; Tanaka A; Matsuda A; Jung K; Oida K; Nishikawa S; Jang H; Matsuda H
J Small Anim Pract; 2013 Jul; 54(7):377-80. PubMed ID: 23614673
[TBL] [Abstract][Full Text] [Related]
10. KIT gene exon 11 mutations in canine malignant melanoma.
Chu PY; Pan SL; Liu CH; Lee J; Yeh LS; Liao AT
Vet J; 2013 May; 196(2):226-30. PubMed ID: 23069279
[TBL] [Abstract][Full Text] [Related]
11. Validation of the prognostic value of histopathological grading or c-kit mutation in canine cutaneous mast cell tumours: a retrospective cohort study.
Takeuchi Y; Fujino Y; Watanabe M; Takahashi M; Nakagawa T; Takeuchi A; Bonkobara M; Kobayashi T; Ohno K; Uchida K; Asano K; Nishimura R; Nakayama H; Sugano S; Ohashi Y; Tsujimoto H
Vet J; 2013 Jun; 196(3):492-8. PubMed ID: 23384436
[TBL] [Abstract][Full Text] [Related]
12. The value of molecular expression of KIT and KIT ligand analysed using real-time polymerase chain reaction and immunohistochemistry as a prognostic indicator for canine cutaneous mast cell tumours.
Costa Casagrande TA; de Oliveira Barros LM; Fukumasu H; Cogliati B; Chaible LM; Dagli ML; Matera JM
Vet Comp Oncol; 2015 Mar; 13(1):1-10. PubMed ID: 23294979
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of exon 11 internal tandem duplications in the C-KIT proto-oncogene in Australian canine mast cell tumours.
Tamlin VS; Kessell AE; Mccoy RJ; Dobson EC; Smith TS; Hebart M; Brown L; Mitrovic D; Peaston AE
Aust Vet J; 2017 Oct; 95(10):386-391. PubMed ID: 28948627
[TBL] [Abstract][Full Text] [Related]
14. In situ c-KIT mRNA quantification of canine cutaneous mast cell tumours and its relationship to prognostic factors.
Seung BJ; Cho SH; Kim SH; Bae MK; Lim HY; Sur JH
Vet Comp Oncol; 2021 Mar; 19(1):132-139. PubMed ID: 32926564
[TBL] [Abstract][Full Text] [Related]
15. HSP32 and HSP90 Immunoexpression, in Relation to Kit Pattern, Grading, and Mitotic Count in Canine Cutaneous Mast Cell Tumors.
Romanucci M; Massimini M; Ciccarelli A; Malatesta D; Bongiovanni L; Gasbarre A; Della Salda L
Vet Pathol; 2017 Mar; 54(2):222-225. PubMed ID: 27627984
[TBL] [Abstract][Full Text] [Related]
16. CD25 is expressed by canine cutaneous mast cell tumors but not by cutaneous connective tissue mast cells.
Meyer A; Gruber AD; Klopfleisch R
Vet Pathol; 2012 Nov; 49(6):988-97. PubMed ID: 22446323
[TBL] [Abstract][Full Text] [Related]
17. Proof of target for SU11654: inhibition of KIT phosphorylation in canine mast cell tumors.
Pryer NK; Lee LB; Zadovaskaya R; Yu X; Sukbuntherng J; Cherrington JM; London CA
Clin Cancer Res; 2003 Nov; 9(15):5729-34. PubMed ID: 14654558
[TBL] [Abstract][Full Text] [Related]
18. Internal Tandem Duplication of Exon 8 of
Brocks BAW; Bertram CA; Bartel A; Kirpensteijn J; Collins-Webb A; Catlin C; Thaiwong T; Kiupel M
Vet Pathol; 2021 Mar; 58(2):315-324. PubMed ID: 33231140
[TBL] [Abstract][Full Text] [Related]
19. TSLC1 tumour-suppressor gene expression in canine mast cell tumours.
Taylor F; Murphy S; Hoather T; Dobson J; Scase T
Vet Comp Oncol; 2010 Dec; 8(4):263-72. PubMed ID: 21062408
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of histologic and immunohistochemical features in feline cutaneous mast cell tumors.
Sabattini S; Bettini G
Vet Pathol; 2010 Jul; 47(4):643-53. PubMed ID: 20418469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
